Update October 2025: Smart Reporting has since been renamed Jacobian.
Smart Reporting has a voice-activated AI-supported reporting software for radiology, pathology, and other clinical areas. It produces fully analyzable and machine-readable reports that are intended to shorten the time required for diagnosis while simultaneously improving the quality of the findings. The Munich-based company is thus contributing to the digitalization of the healthcare system by automating previously manual processes. Furthermore, the data collected in hospitals is being made available for later analysis, for example, for medical research.
The EIB is now supporting Smart Reporting's further growth with a €15 million venture debt loan. The financing is supported by the InvestEU program, which provides investment partners with an EU budget guarantee to increase their risk capacity and thus mobilize public and private investment. Venture debt loans complement existing venture capital financing without diluting the founders' stakes. Smart Reporting plans to use the fresh capital to enter new markets and further scale its software and data business.
“Strategic importance for the digitalization of healthcare”
Ambroise Fayolle, EIB-Vice President with responsibility for financing in Germany, says:
"Smart Reporting develops effective solutions to accelerate standard procedures and diagnostics in medical practices and hospitals, incorporating the latest medical information and guidelines. The technology is strategically important for the digitalization of healthcare and makes previously collected data usable for further diagnostics and medical research. We are pleased to be working with Smart Reporting to advance this innovation in medicine."
Wieland Sommer, founder and co-CEO of Smart Reporting, explains:
"The future of medicine is data-driven. Only with high-quality, standardized data can we profoundly automate clinical workflows, enable evidence-based decision-making, and ensure high-quality and efficient medical care in the future. In recent years, we have established global market access through a growing number of partnerships with leading international technology companies. We are delighted to have found a strong, long-term partner in the EIB, with whose support we will significantly accelerate our expansion into new markets such as the USA and Canada, as well as into other application areas, such as surgical documentation."
And Peter Vanovertveld, Co-CEO of Smart Reporting, adds:
"We are ideally positioned in the market because Smart Reporting is the leading technology-driven provider that structures clinical data directly where it is created. The virtually unique interoperability of our software and its seamless integration into the clinical workflow enables us to generate consistently complete and quality-controlled data. With this fresh capital, we are now taking the next step in the company's development, focusing even more on the use of data in the clinical environment and in drug development. In this area, as in the entire healthcare system, data and its quality are the key to success. We are ready with the additional financial resources to make a significant contribution to this development."
